Antidepressant Unsafe for Teens
Wednesday, 08 Feb 2017 04:26 PM
Years ago, Big Pharma company SmithKline Beecham (now part of GlaxoSmithKline) published a prominent study in the Journal of the American Academy of Child and Adolescent Psychiatry that concluded the popular antidepressant medication, Paxil, was safe and effective for teenagers.
But in September 2015, the British Medical Journal posted a re-analysis of the original data — and concluded that the opposite is true.
There have been many reports of young people taking or withdrawing from antidepressants, especially Paxil, and committing violent acts, even suicide.
The original study compared the responses of adolescents taking Paxil or a placebo to a group taking an older antidepressant called imipramine. The Paxil group did not perform better than the other groups for depression.
After the study was published, SmithKline Beecham submitted the trial to the FDA for approval in treating adolescents.
Of course, the FDA approved their application and Big Pharma ramped up their marketing of Paxil for teenagers.
Guess what happened next? Prescriptions of antidepressants to our youth increased by 36 percent from 2002 to 2003.
The 2015 article that reanalyzed the data reported that Paxil has no clear effectiveness, and there was mislabeling of serious side effects.
Antidepressant drugs are a disaster. They barely perform better than a placebo. Exercise outperforms antidepressants in nearly every study that compares the two.
I don’t think these drugs need to be pulled from the market completely, but they should not be as widely prescribed.
There are many natural therapies that can combat depression. The best therapy starts with the basics: Drink an adequate amount of water and eat a healthy diet.